Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The pharmaco-epigenetics of hypertension: a focus on microRNA

29 Feb 2024

Abstract excerpt

Hypertension is a major harbinger of cardiovascular morbidity and mortality. It predisposes to higher rates of myocardial infarction, chronic kidney failure, stroke, and heart failure than most other risk factors. By 2025, the prevalence of hypertension is projected to reach 1.5 billion people. The pathophysiology of this disease is multifaceted, as it involves nitric oxide and endothelin dysregulation, reactive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adipokines, Inflammation, and Metabolic Diseases
Share to Cancer-related molecular mechanisms research
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38424404
DOI: 10.1007/s11010-024-04947-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The pharmaco-epigenetics of hypertension: a focus on microRNAPMID 38424404Read ↗

MicroRNAs (miRNAs) role in hypertension: pathogenesis and promising therapeuticsSemantic proximity Read ↗

MicroRNAs (miRNAs) Role in Hypertension: Pathogenesis and Promising TherapeuticsSemantic proximity Read ↗

Hypertensive epigenetics: from DNA methylation to microRNAsSemantic proximity Read ↗

Summary of Known Genetic and Epigenetic Modification Contributed to HypertensionSemantic proximity Read ↗

Epigenetics, microRNA and Metabolic Syndrome: A Comprehensive Review.Semantic proximity Read ↗

Report of the National Heart, Lung, and Blood Institute Working Group on epigenetics and hypertension.Semantic proximity Read ↗

DNA Methylation and Histone Modification in HypertensionSemantic proximity Read ↗

The emerging role of non-coding RNA in essential hypertension and blood pressure regulation.Semantic proximity Read ↗

Classical and microRNA Regulated Epigenetic Mechanisms as Potential Mediators of the Metabolic SyndromeSemantic proximity Read ↗

Epigenetic Signatures in Arterial Hypertension: Focus on the MicrovasculatureSemantic proximity Read ↗

Integrating epigenetics and metabolomics to advance treatments for pulmonary arterial hypertensionSemantic proximity Read ↗

Epigenetic Modifications: Basic Mechanisms and Role in Cardiovascular Disease (2013 Grover Conference Series)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.